Nele D.
- Country
- Belgium
- Department
- Gastro-enterology
Research Overview
- A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis
- Efficacy and Safety of Obefazimod (ABX464) in Adults with Moderately to Severely Active Ulcerative Colitis: A Randomized Placebo‑Controlled Phase III Study
- Evaluation of Guselkumab and Golimumab Combination Therapy Efficacy and Safety in Moderate to Severe Ulcerative Colitis: A Phase 2b Randomized Controlled Trial
Data & Insights
Has run more than one trial at 183 of 354 partner sites.
Specializations
Inflammatory Bowel Disease Therapeutics
This investigator specializes in researching innovative treatments for inflammatory bowel diseases, with particular emphasis on both ulcerative colitis and Crohn's disease. Their work encompasses evaluating novel therapeutic agents and established treatments for patients with moderate to severe disease activity.
- Novel Therapeutic Compounds
- Biological Response Modulators
- Treatment Optimization Strategies
Key interests include investigating targeted therapies and combination treatment approaches for inflammatory conditions.
Advanced Treatment Modalities
The investigator focuses on examining various drug administration routes and their impact on treatment outcomes, including both subcutaneous and intravenous delivery methods. Their research explores maintenance therapy strategies and long-term treatment efficacy.
- Drug Delivery Systems
- Treatment Response Assessment
- Long-term Efficacy Monitoring
Areas of investigation include optimizing dosing regimens and evaluating treatment durability in chronic conditions.
Clinical Remission Studies
Research activities center on achieving and maintaining clinical remission in patients with inflammatory conditions. The investigator studies endoscopic improvement markers and therapeutic responses in treatment-resistant cases.
- Remission Indicators
- Disease Activity Monitoring
- Treatment Response Patterns
Special attention is given to evaluating symptomatic improvement and maintaining long-term disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.